Streetbeat News

Earnings

STNE

StoneCo Ltd. (Nasdaq: STNE) released its financial results for Q4 and fiscal year 2024, available on their Investor Relations website.

Portfolio Pulse from

March 18, 2025 | 8:15 pm

PET

Wag! Group Co. (Nasdaq: PET) will release its Q4 and full year 2024 financial results on March 24, 2025, before market open. A conference call will follow at 8:30 a.m. ET to discuss the results.

Portfolio Pulse from

March 18, 2025 | 8:15 pm

INO

INOVIO reported its Q4 and full-year 2024 financial results, highlighting progress on its INO-3107 BLA for RRP treatment and resolving manufacturing issues. Promising interim results from a Phase 1 trial for COVID-19 DMAb were also announced.

Portfolio Pulse from

March 18, 2025 | 8:15 pm

VTSI

VirTra, Inc. (Nasdaq: VTSI) will hold a conference call on March 27, 2025, to discuss its Q4 and full-year 2024 financial results. The results will be released in a press release before the call.

Portfolio Pulse from

March 18, 2025 | 8:15 pm

TRVI

Trevi Therapeutics reported positive results from its Phase 2a RIVER trial for Haduvio in treating refractory chronic cough and idiopathic pulmonary fibrosis. The company completed enrollment for the Phase 2b CORAL trial and expects results in Q2 2025. Trevi ended 2024 with $107.6 million in cash, providing a runway into the second half of 2026.

Portfolio Pulse from

March 18, 2025 | 8:15 pm

ATER

Aterian has released its financial results for Q4 and the full year 2024, introduced its annual guidance for 2025, and announced a $3 million share repurchase program.

Portfolio Pulse from

March 18, 2025 | 8:15 pm

OLMA

Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) reported its financial and operating results for Q4 and full year 2024. The company focuses on developing targeted therapies for breast cancer.

Portfolio Pulse from

March 18, 2025 | 8:15 pm

ABSI

AMD

Absci Corporation reported its Q4 and full-year 2024 financial results, highlighting collaborations with AMD and other partners, and a strategic investment from AMD. The company has sufficient funds to operate into 2027.

Portfolio Pulse from

March 18, 2025 | 8:15 pm

REXR

Rexford Industrial Realty, Inc. (NYSE: REXR) will release its Q1 2025 financial results on April 16, 2025, followed by a conference call on April 17, 2025.

Portfolio Pulse from

March 18, 2025 | 8:15 pm

OCX

Oncocyte Corp. (Nasdaq: OCX) will release its fourth quarter 2024 financial results on March 24, 2025, after the market closes.

Portfolio Pulse from

March 18, 2025 | 8:15 pm